Global Aquaculture Market Size to Grow by USD 209.42 Billion in 2021: Zion Market Research
/
Date26 Jan 2018
Sarasota, FL, Jan. 25, 2018 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Aquaculture Market (Carp, Molluscs, Crustaceans, Salmon, Trout and... Read More →
DPW Holdings Appoints William B. Horne CFO and Executive Vice President
/
Date26 Jan 2018
FREMONT, CA., Jan. 26, 2018 (GLOBE NEWSWIRE) — DPW Holdings, Inc. (NYSE American: DPW) (“DPW” or the “Company“), a diversified holding company, stated today that... Read More →
Sprague Resources LP Announces Cash Distribution for the Fourth Quarter of 2017 and Earnings Conference Call Schedule
/
Date26 Jan 2018
PORTSMOUTH, N.H., Jan. 26, 2018 (GLOBE NEWSWIRE) — Sprague Resources LP (“Sprague”) (NYSE:SRLP) announced today that the Board of Directors of its general partner, Sprague... Read More →
Orla Acquires Monitor Gold Exploration Project in Central Nevada
/
Date26 Jan 2018
Monitor Project Nevada USA Orla Mining Ltd. VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) — Orla Mining Ltd. (TSX VENTURE:OLA) (“Orla” or the “Company”)... Read More →
$9 Million Oceanfront Estate Recorded as Highest Sale in Greater Victoria Since 2006
/
Date26 Jan 2018
9344 Ardmore Drive – 1 9344 Ardmore Drive – Exterior Sotheby’s International Realty Canada 9344 Ardmore Drive – 3 9344 Ardmore Drive – Aerial View... Read More →
TOPDANMARK ÅRSREGNSKABSMEDDELELSE 2017
/
Date26 Jan 2018
TOPDANMARK ÅRSREGNSKABSMEDDELELSE 2017 25. januar 2018 Meddelelse nr. 02/2018 Hovedelementer 2017 Resultat efter skat: 1.733 mio. kr. (2016: 1.536 mio. kr.) Resultat pr. aktie: 20,2... Read More →
Adverum Biotechnologies and Editas Medicine Extend Research Collaboration
/
Date26 Jan 2018
MENLO PARK, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare... Read More →
resTORbio Announces Pricing of Initial Public Offering
/
Date26 Jan 2018
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) — resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment... Read More →